We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MGLN
1601
DELISTED
Magellan Health Services, Inc.
MGLN
| $894K | ﹤0.01% |
9,591
-17,367
| -64% | -$1.63M |
|
1602
DHT Holdings
DHT
$2.93B
| $893K | ﹤0.01% |
150,651
+122,586
| +437% | +$712K |
|
|
SPR
1603
DELISTED
Spirit AeroSystems
SPR
| $892K | ﹤0.01% |
18,330
-1,181
| -6% | -$50.6K |
|
1604
Solid Biosciences
SLDB
$949M
| $889K | ﹤0.01% |
+10,723
| New | +$1.19M |
|
1605
TriNet
TNET
$3.06B
| $888K | ﹤0.01% |
11,388
+771
| +7% | +$62.2K |
|
1606
Clearwater Paper
CLW
$366M
| $886K | ﹤0.01% |
23,545
-804
| -3% | -$32.1K |
|
1607
Mercantile Bank Corp
MBWM
$1.05B
| $883K | ﹤0.01% |
+27,206
| New | +$820K |
|
1608
LGI Homes
LGIH
$1.34B
| $882K | ﹤0.01% |
5,905
-6,343
| -52% | -$762K |
|
|
SPLK
1609
DELISTED
Splunk Inc
SPLK
| $882K | ﹤0.01% |
6,517
-6,879
| -51% | -$1.07M |
|
|
SNP
1610
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $882K | ﹤0.01% |
16,731
-4,870
| -23% | -$254K |
|
|
FOLD
1611
DELISTED
Amicus Therapeutics
FOLD
| $878K | ﹤0.01% |
88,891
-56,821
| -39% | -$880K |
|
1612
Preferred Bank
PFBC
$1.27B
| $875K | ﹤0.01% |
13,747
+990
| +8% | +$55.9K |
|
|
BPFH
1613
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $875K | ﹤0.01% |
65,721
-241,171
| -79% | -$3.22M |
|
|
MDP
1614
DELISTED
Meredith Corporation
MDP
| $873K | ﹤0.01% |
29,301
-5,968
| -17% | -$158K |
|
|
QUOT
1615
DELISTED
Quotient Technology Inc
QUOT
| $869K | ﹤0.01% |
53,163
-18,739
| -26% | -$231K |
|
|
MSGN
1616
DELISTED
MSG Networks Inc.
MSGN
| $863K | ﹤0.01% |
57,392
+22,209
| +63% | +$372K |
|
|
AAT
1617
American Assets Trust
AAT
$1.37B
| $861K | ﹤0.01% |
26,555
-32,117
| -55% | -$993K |
|
|
HONE
1618
DELISTED
HarborOne Bancorp
HONE
| $860K | ﹤0.01% |
63,839
+52,405
| +458% | +$637K |
|
1619
Strategy Inc
MSTR
$37.8B
| $857K | ﹤0.01% |
12,620
-5,300
| -30% | -$374K |
|
1620
Clarus
CLAR
$146M
| $853K | ﹤0.01% |
50,014
+18,963
| +61% | +$322K |
|
1621
LiveOne
LVO
$62.8M
| $852K | ﹤0.01% |
19,634
+15,550
| +381% | +$663K |
|
1622
Evolent Health
EVH
$464M
| $850K | ﹤0.01% |
42,070
-61,566
| -59% | -$1.17M |
|
1623
Q2 Holdings
QTWO
$3.95B
| $850K | ﹤0.01% |
8,483
-2,184
| -20% | -$272K |
|
|
FARO
1624
DELISTED
Faro Technologies
FARO
| $849K | ﹤0.01% |
9,804
+3,449
| +54% | +$286K |
|
1625
Rockwell Medical
RMTI
$27.9M
| $848K | ﹤0.01% |
6,644
+2,799
| +73% | +$414K |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.